Cargando…
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
The aim of this study was to develop and evaluate the effects of chitosan inserts for sustained release of the angiotensin-converting enzyme 2 (ACE2) activator, diminazene aceturate (DIZE), in experimental glaucoma. Monolayer DIZE loaded inserts (D+I) were prepared and characterized through swelling...
Autores principales: | Foureaux, Giselle, Franca, Juçara Ribeiro, Nogueira, José Carlos, Fulgêncio, Gustavo de Oliveira, Ribeiro, Tatiana Gomes, Castilho, Rachel Oliveira, Yoshida, Maria Irene, Fuscaldi, Leonardo Lima, Fernandes, Simone Odília Antunes, Cardoso, Valbert Nascimento, Cronemberger, Sebastião, Faraco, André Augusto Gomes, Ferreira, Anderson José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512709/ https://www.ncbi.nlm.nih.gov/pubmed/26204514 http://dx.doi.org/10.1371/journal.pone.0133149 |
Ejemplares similares
-
Bimatoprost-Loaded Ocular Inserts as Sustained Release Drug Delivery Systems for Glaucoma Treatment: In Vitro and In Vivo Evaluation
por: Franca, Juçara Ribeiro, et al.
Publicado: (2014) -
Development of unstable resistance to diminazene aceturate in Babesia bovis
por: Tuvshintulga, Bumduuren, et al.
Publicado: (2019) -
Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice
por: Yoon, So Hye, et al.
Publicado: (2022) -
Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis
por: Zheng, Changwei, et al.
Publicado: (2015) -
Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding
por: Wang, Li-Fang, et al.
Publicado: (2021)